Sustained intestinal epithelial monolayer wound closure after transient application of a FAK-activating small molecule

• Published in: PloS one 2024-08, Vol.19 (8), p.e0304010
• Main Authors: Oncel, Sema, Wang, Qinggang, Elsayed, Ahmed Adham R, Vomhof-DeKrey, Emilie E, Brown, Nicholas D, Golovko, Mikhail Y, Golovko, Svetlana A, Gallardo-Macias, Ricardo, Gurvich, Vadim J, Basson, Marc D
• Format: Article
• Language: English
• Subjects: Acids; Actin; Amides - pharmacology; Animals; Antibodies; Caco-2 Cells; Cell activation; Cell culture; Cell Movement - drug effects; Cell number; Comparative analysis; Enzyme inhibitors; Epithelial Cells - drug effects; Epithelial Cells - metabolism; Ethylenediaminetetraacetic acid; Exposure; Extracellular signal-regulated kinase; Focal adhesion kinase; Focal Adhesion Kinase 1 - metabolism; Focal Adhesion Protein-Tyrosine Kinases - metabolism; Half-life; Humans; In vivo methods and tests; Inflammatory bowel disease; Intestinal Mucosa - drug effects; Intestinal Mucosa - metabolism; Intestine; Ischemia; Kinases; Mass spectrometry; Mass spectroscopy; Monolayers; Mucosa; Muscle proteins; Nonsteroidal anti-inflammatory drugs; Proteins; Pyridines - pharmacology; Rho-associated kinase; Scientific imaging; Toxicity; Wound healing; Wound Healing - drug effects
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0304010

M64HCl, which has drug-like properties, is a water-soluble Focal Adhesion Kinase (FAK) activator that promotes murine mucosal healing after ischemic or NSAID-induced injury. Since M64HCl has a short plasma half-life in vivo (less than two hours), it has been administered as a continuous infusion with osmotic minipumps in previous animal studies. However, the effects of more transient exposure to M64HCl on monolayer wound closure remained unclear. Herein, we compared the effects of shorter M64HCl treatment in vitro to continuous treatment for 24 hours on monolayer wound closure. We then investigated how long FAK activation and downstream ERK1/2 activation persist after two hours of M64HCl treatment in Caco-2 cells. M64HCl concentrations immediately after washing measured by mass spectrometry confirmed that M64HCl had been completely removed from the medium while intracellular concentrations had been reduced by 95%. Three-hour and four-hour M64HCl (100 nM) treatment promoted epithelial sheet migration over 24 hours similar to continuous 24-hour exposure. 100nM M64HCl did not increase cell number. Exposing cells twice with 2-hr exposures of M64HCl during a 24-hour period had a similar effect. Both FAK inhibitor PF-573228 (10 μM) and ERK kinase (MEK) inhibitor PD98059 (20 μM) reduced basal wound closure in the absence of M64HCl, and each completely prevented any stimulation of wound closure by M64HCl. Rho kinase inhibitor Y-27632 (20 μM) stimulated Caco-2 monolayer wound closure but no further increase was seen with M64HCl in the presence of Y-27632. M64HCl (100 nM) treatment for 3 hours stimulated Rho kinase activity. M64HCl decreased F-actin in Caco-2 cells. Furthermore, a two-hour treatment with M64HCl (100 nM) stimulated sustained FAK activation and ERK1/2 activation for up to 16 and hours 24 hours, respectively. These results suggest that transient M64HCl treatment promotes prolonged intestinal epithelial monolayer wound closure by stimulating sustained activation of the FAK/ERK1/2 pathway. Such molecules may be useful to promote gastrointestinal mucosal repair even with a relatively short half-life.